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Psychotic-like experiences in the general population:
characterizing a high-risk group for psychosis
I. Kelleher1* and M. Cannon1,2
1 Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland
2 Department of Psychiatry, Beaumont Hospital, Dublin, Ireland
Recent research shows that psychotic symptoms, or psychotic-like experiences (PLEs), are reported not only by
psychosis patients but also by healthy members of the general population. Healthy individuals who report these
symptoms are considered to represent a non-clinical psychosis phenotype, and have been demonstrated to be at
increased risk of schizophrenia-spectrum disorder. Converging research now shows that this non-clinical psychosis
phenotype is familial, heritable and covaries with familial schizophrenia-spectrum disorder. A review of the research
also shows that the non-clinical phenotype is associated extensively with schizophrenia-related risk factors, including
social, environmental, substance use, obstetric, developmental, anatomical, motor, cognitive, linguistic, intellectual
and psychopathological risk factors. The criterion and construct validity of the non-clinical psychosis phenotype with
schizophrenia demonstrates that it is a valid population in which to study the aetiology of psychosis. Furthermore, it
suggests shared genetic variation between the clinical and non-clinical phenotypes. Much remains to be learned
about psychosis by broadening the scope of research to include the non-clinical psychosis phenotype.
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Introduction
Psychotic symptoms, as highlighted by recent re-
search, are experienced not just by patients with psy-
chiatric disorders but also by a substantial proportion
of the general healthy population. In the absence
of illness, these symptoms are also referred to as
psychotic-like experiences (PLEs) or subclinical psy-
chotic symptoms. A recent meta-analysis by van Os
et al. (2009) reported a median prevalence of 5–8% for
these symptoms in the general population. Data on
adolescents suggest that rates of PLEs are even higher
among this age group (Poulton et al. 2000 ; Spauwen
et al. 2003 ; Yoshizumi et al. 2004; Laurens et al. 2007).
Clinical cases of psychosis, then, represent only a
small proportion of the total phenotypic continuum
of psychosis, with the major proportion made up of
a much commoner non-clinical psychosis phenotype
(individuals who experience PLEs).
PLEs share criterion validity with clinical psychosis
A clinical continuum between PLEs and psychotic
disorder was demonstrated in an inﬂuential paper
from the Dunedin birth cohort study (Poulton et al.
2000). Children aged 11 years who reported psy-
chotic symptoms were shown to be at a 5- to 16-fold
increased risk of schizophrenia-spectrum disorder
in adulthood. This ﬁnding was replicated in an
Australian sample by Welham et al. (2009), who
showed that self-reported auditory hallucinations at
age 14 years were associated with increased risk for
psychotic disorder at age 21. Similarly, in the general
adult population, Hanssen et al. (2005) found that 8%
of those who experienced PLEs were clinically psy-
chotic 2 years later. Individuals who report PLEs (the
non-clinical psychosis phenotype) can therefore be
considered to represent a high-risk group for psy-
chotic illness. As with research involving the oﬀspring
of parents with psychotic disorders (the ‘genetic ’
high-risk approach), research with persons who report
PLEs also provides a unique high-risk paradigm for
studying the developmental trajectory to psychosis
(the ‘symptomatic ’ high-risk approach).
PLEs share construct validity with clinical
psychosis
In the elegant paper by Mackie et al. (2010), in addition
to identifying two discrete developmental trajectories
for PLEs (‘persistent ’ and ‘ increasing’), the authors
identify several risk factors associated with these
symptoms that have previously been recognized as
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risk factors for schizophrenia ; namely, victimization
(with associated elevated depressive and anxiety
scores) and substance use. These ﬁndings add to the
growing body of information on PLEs and the overlap
with risk factors for schizophrenia. A wide range of
risk factors for schizophrenia has now been in-
vestigated in individuals who report PLEs and some
striking similarities have emerged between the non-
clinical and clinical populations, demonstrating con-
struct validity between the clinical and non-clinical
phenotypes.
Familiality and heritability
Hanssen et al. (2006) investigated PLEs among 257
members of the general population and reported
familial clustering of the symptoms, in line with ﬁnd-
ings in family and adoption studies in schizophrenia.
Furthermore, Polanczyk et al. (2010) have shown fam-
ilial covariation of PLEs with maternal schizophrenia-
spectrum disorder, and also with family psychiatric
hospitalizations and family suicide attempts. Twin
studies have also established that PLEs are heritable,
with studies showing greater concordance for PLEs
among monozygotic than dizygotic twins (Lataster
et al. 2009 ; Polanczyk et al. 2010). Research on con-
tributing genes or loci, however, is lacking.
Schizophrenia-related social risk factors
An elevated incidence of schizophrenia has been con-
sistently demonstrated among migrant and ethnic
minority groups, particularly African-Caribbeans in
the UK (Fearon et al. 2006). Johns et al. (2002) found a
similar pattern among individuals who report PLEs,
with persons of African-Caribbean descent 2.5 times
more likely to admit to hallucinations than the white
British population. Similarly, Laurens et al. (2008)
found that PLEs were more commonly reported by
British children of African-Caribbean ethnicity than by
white British children. Although they did not ﬁnd a
signiﬁcant association with migration status, a larger
representative Australian study of more than 10000
people showed that migrants from non-English-
speaking backgrounds were more likely to report
PLEs on interview (Scott et al. 2006). Further social
risk factors for schizophrenia, including unemploy-
ment, lower socio-economic background and being
unwed or divorced, were also replicated in this large
Australian sample. Similarly, a higher rate of urbani-
city, one of the most frequently reported ﬁndings in
schizophrenia (Krabbendam & van Os, 2005), was also
demonstrated in association with PLEs.
Schizophrenia-related adverse childhood experiences
risk factors
The prevalence of PLEs has been shown to be greater
in adolescents who have had traumatic experiences,
including physical abuse (Kelleher et al. 2008), un-
wanted sexual experiences (Lataster et al. 2006) and
exposure to domestic violence (Kelleher et al. 2008).
An association has also been reported between peer
victimization and risk of PLEs, with higher rates of
PLEs reported by victims of bullying (Campbell &
Morrison, 2007 ; Schreier et al. 2009 ; Mackie et al. 2010),
but also, conversely, by perpetrators of bullying
(Kelleher et al. 2008; Nishida et al. 2008) and, most
strikingly, by children who are both victims and
perpetrators of bullying (‘bully/victims’) (Kelleher
et al. 2008). Mothers of children with PLEs have also
been demonstrated to show increased levels of nega-
tive expressed emotion, although no diﬀerence was
found in terms of maternal warmth (Polanczyk et al.
2010).
Schizophrenia-related substance use risk factors
The well-established relationship between psychotic
disorder and cannabis use has been replicated in ado-
lescents with PLEs (Miettunen et al. 2008 ; Harley et al.
2009). In their paper, Mackie et al. (2010) show that
among adolescents who follow a trajectory of increas-
ing PLEs over 2 years, a rise in cannabis use preceded
a sharp increase in symptoms. Henquet et al. (2005),
similarly, showed that the risk for PLEs among ado-
lescents and young adults increased in a dose–
response manner relative to the frequency of cannabis
use over a 4-year period. Harley et al. (2009) demon-
strated an interesting synergistic interaction between
cannabis use and traumatic childhood events, with
exposure to both variables associated with a greater
risk of PLEs than the summed risk that each variable
accounted for individually. Both alcohol dependence
and tobacco use have also been shown to be more
common among individuals who report PLEs (Johns
et al. 2004 ; Wiles et al. 2006).
Schizophrenia-related obstetric and developmental
deﬁcits
Adverse prenatal and perinatal events, including
maternal infection and obstetric complications, are
well documented in schizophrenia (Clarke et al. 2006,
2009). These ﬁndings have been replicated in persons
who report PLEs (Zammit et al. 2009). Neuromotor
deﬁcits have also been demonstrated among ado-
lescents who report PLEs (Cannon et al. 2002 ;
Blanchard et al., in press). However, associations with
advanced paternal age and with winter and spring
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births have failed to be shown (Zammit et al. 2008 ;
Polanczyk et al. 2010).
Schizophrenia-related neuroanatomical
abnormalities
Neuroimaging research has demonstrated signiﬁcant
overlaps between the clinical and non-clinical psy-
chosis phenotypes. The typical functional magnetic
resonance imaging (fMRI) proﬁle of hypofrontality in
schizophrenia has been replicated in adolescents who
report PLEs, particularly in relation to the right cer-
ebral hemisphere, and the classic frontotemporal dis-
connection now well established in clinical psychosis
(Friston & Frith, 1995) has also been demonstrated
(Jacobson et al. 2010). Deﬁcits in white matter integrity
have been identiﬁed, in addition to grey matter ab-
normalities, although, of interest, adolescents who re-
ported PLEs demonstrated larger grey matter volumes
in contrast to the grey matter deﬁcits typically seen in
schizophrenia (Jacobson et al. 2010).
Schizophrenia-related deﬁcits in IQ, cognition
and language
Lower IQ scores have been demonstrated in the non-
clinical psychosis population, as in schizophrenia
(Cannon et al. 2002 ; Johns et al. 2004 ; Horwood et al.
2008). To date, however, there have been few studies
of cognition for the non-clinical phenotype. Deﬁcits in
receptive, though not expressive, language have been
reported among adolescents with PLEs (Cannon et al.
2002 ; Blanchard et al., in press). Blanchard et al.
(in press) also demonstrated deﬁcits in speed of pro-
cessing in the non-clinical phenotype. Men who report
PLEs have been shown to perform worse in tests of
verbal ﬂuency (Krabbendam et al. 2005).
Schizophrenia-related co-morbid psychopathology
Nishida et al. (2008) assessed a general population
sample of more than 5000 adolescents for both the
presence of PLEs and a range of psychopathologies.
Adolescents who reported PLEs showed increased
levels of anxiety, suicidal ideation and self-harm
behaviours. Scott et al. (2009) found that adolescents
who reported PLEs scored higher in symptoms of de-
pression and were 2.7 times more likely to receive a
diagnosis of depressive disorder. PLEs were also as-
sociated with child psychopathology on parent-rated
measures. Polanczyk et al. (2010) replicated the ﬁnd-
ings for depressive and anxiety symptoms and self-
harm and suicidal behaviour, and also demonstrated
an increase in antisocial behaviour among adolescents
who reported PLEs.
Discussion and implications
The past decade of research summarized above illus-
trates a non-ambiguous continuum between the clini-
cal and non-clinical psychosis phenotypes in the
general population. PLEs are familial, heritable, confer
increased risk for schizophrenia-spectrum disorder
and covary with maternal psychotic disorder. Further-
more, these symptoms share an extensive range of
social, environmental, substance use, obstetric, devel-
opmental, anatomical, motor, cognitive, linguistic, in-
tellectual and psychopathological risk factors with
schizophrenia (see Table 1).
Although the rapid nervous system changes that
take place in adolescence are recognized to be of great
signiﬁcance in the development of clinical psychosis,
the low disease incidence hinders attempts to
study the developmental trajectory in large numbers
prior to the onset of illness (given that only about one
in every hundred children studied will develop
schizophrenia). The ﬁndings presented here, however,
demonstrate that the non-clinical psychosis phenotype
represents a valuable, and valid, population in which
to study the aetiology of psychosis, with the further
advantages that this non-clinical phenotype (i) is more
prevalent than the clinical (disease) phenotype, thus
increasing the population pool for study, (ii) can
be screened for using a validated brief questionnaire
(Kelleher et al. 2009) and (iii) facilitates research into
early (pre-morbid, pre-medication) neurodevelop-
mental changes in psychosis.
Much has been learned about this population, but
more remains to be discovered, especially in terms of
neuro-genetics, -cognition and -anatomy. Genetic re-
search may be particularly valuable in elucidating the
molecular mechanisms underlying psychosis because
the construct and criterion validity between the clini-
cal and non-clinical psychosis phenotypes suggests
that genetic risk may be shared between both. That
is, genetic risk for psychosis may relate to the
broader (clinical and non-clinical) psychosis pheno-
type rather than speciﬁcally to psychotic disorder.
Genetic research to date has used the simple dichot-
omy of persons with psychotic disorder compared to
the general population. However, the reasonably
common non-clinical psychosis phenotype in the
general population may have masked genes of im-
portance.
The identiﬁcation of a non-clinical psychosis
phenotype raises interesting evolutionary questions
(Kelleher et al., in press). Psychotic disorders are
highly heritable and exert strong negative ﬁtness
eﬀects but persist despite selective disadvantage. The
identiﬁcation of a non-clinical psychosis phenotype,
however, opens up the possibility that there may
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be selective advantages associated with genes
that contribute to this phenotype but that also increase
the risk for psychotic disorder. This biological
compromise is not unique to psychosis ; for example,
genes that have been positively selected due to their
protective eﬀects against malarial infection bring
with them the risk of sickle cell disease. Further in-
vestigation of this non-clinical population may help
us to ﬁnally uncover an evolutionary basis for the
persistence of psychosis genes in the general popu-
lation.
Conclusions
Previous views of psychotic symptomatology as
intrinsically pathological have been replaced by the
idea that, in many cases, psychotic symptoms may
fall within a spectrum of normal experience. None-
theless, these symptoms are associated with increased
risk for psychotic disorder and show criterion and
construct validity for clinical psychosis. PLEs are
familial, heritable, confer increased risk for schizo-
phrenia-spectrum disorder, covary with maternal
Table 1. Aetiological and risk factor continuity between clinical and non-clinical psychosis phenotypes
Category Risk factor
Schizophrenia
(clinical
psychosis
phenotype)
PLEs (non-
clinical
psychosis
phenotype)
Genetics/transmission Familial + +
Heritable + +
Social Urbanicity + +
Migration + +
Ethnic minority + +
Low socio-economic background + +
Unemployed + +
Unmarried/divorced + +
Adverse childhood experiences Traumatic childhood physical or sexual experiences + +
Bullying/victimization + +
Parental domestic violence + +
Maternal expressed emotion : negativity + +
Maternal expressed emotion : warmth + x
Substance use Cannabis use + +
Tobacco use + +
Alcohol dependence + +
Obstetric and developmental deﬁcits Obstetric complications + +
Maternal infection + +
Neuromotor deﬁcits + +
Winter/spring birth + x
Paternal age + x
Neuroanatomy Hypofrontality + +
Frontotemporal disconnection + +
Grey matter abnormalities + +
White matter abnormalities + +
Cognition and language Verbal ﬂuency + +
Receptive language + +
Expressive language + x
Speed of processing + +
Intelligence IQ + +
Psychopathology Depressive symptoms + +
Anxiety symptoms + +
Suicidal ideation + +
Self-harm + +
Antisocial behaviour + +
PLE, Psychotic-like experience.
+, Positive ﬁndings ;x, negative ﬁndings.
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schizophrenia-spectrum disorder and share an exten-
sive range of risk factors with schizophrenia. These
ﬁndings indicate that the non-clinical psychosis
phenotype represents a valid population for studying
the aetiology of clinical psychosis and suggest a
shared genetic aetiology between the clinical and non-
clinical phenotypes. Much remains to be learned about
psychosis by broadening the scope of research to in-
clude the non-clinical psychosis population.
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